Shuwen Cao - Search Results

Year	Number of Results
2006	1
2007	5
2008	4
2009	1
2010	2
2011	4
2012	2
2013	2
2014	1
2015	2
2016	3
2017	3
2018	1
2020	3
2021	5
2022	2
2023	2
2024	1

1

RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma.

Yu P, Cao S, Yang SM, Rai G, Martinez NJ, Yasgar A, Zakharov AV, Simeonov A, Molina Arocho WA, Lobel GP, Mohei H, Scott AL, Zhai L, Furth EE, Simon MC, Haldar M. Yu P, et al. Among authors: cao s. Cancer Immunol Res. 2024 Feb 2;12(2):180-194. doi: 10.1158/2326-6066.CIR-22-1023. Cancer Immunol Res. 2024. PMID: 38051215

2

Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.

Zhang W, Liu X, Cao S, Zhang Q, Chen X, Luo W, Tan J, Xu X, Tian J, Saw PE, Luo B. Zhang W, et al. Among authors: cao s. ACS Nano. 2023 Aug 8;17(15):14424-14441. doi: 10.1021/acsnano.2c12498. Epub 2023 Jul 27. ACS Nano. 2023. PMID: 37498878

3

Separation of Emulsions with Fibrous Filter-Coalescers.

Ajogbeje OJ, Stammitti-Scarpone A, Cao S, Akanni T, Ng S, Acosta EJ. Ajogbeje OJ, et al. Among authors: cao s. Langmuir. 2021 Jun 16. doi: 10.1021/acs.langmuir.1c00333. Online ahead of print. Langmuir. 2021. PMID: 34133189

4

TME-Responsive Multistage Nanoplatform for siRNA Delivery and Effective Cancer Therapy.

Cao S, Lin C, Li X, Liang Y, Saw PE. Cao S, et al. Int J Nanomedicine. 2021 Aug 27;16:5909-5921. doi: 10.2147/IJN.S322901. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34475756 Free PMC article. Review.

5

Synthesis, characterization and biological evaluation of paeonol thiosemicarbazone analogues as mushroom tyrosinase inhibitors.

Zhu TH, Cao SW, Yu YY. Zhu TH, et al. Int J Biol Macromol. 2013 Nov;62:589-95. doi: 10.1016/j.ijbiomac.2013.09.056. Epub 2013 Oct 8. Int J Biol Macromol. 2013. PMID: 24120880 Review.

6

Nanostructure Engineering by Simple Tuning of Lipid Combinations.

Saw PE, Xu X, Zhang M, Cao S, Farokhzad OC, Wu J. Saw PE, et al. Among authors: cao s. Angew Chem Int Ed Engl. 2020 Apr 6;59(15):6249-6252. doi: 10.1002/anie.201916574. Epub 2020 Feb 19. Angew Chem Int Ed Engl. 2020. PMID: 32017368

7

Mitochondria-specific delivery system for targeted regulation of mitochondrial gene expression.

Su S, Cao S, Liu J, Xu X. Su S, et al. Among authors: cao s. STAR Protoc. 2021 Jan 15;2(1):100275. doi: 10.1016/j.xpro.2020.100275. eCollection 2021 Mar 19. STAR Protoc. 2021. PMID: 33511358 Free PMC article.

8

Bioactive lipid-nanoparticles with inherent self-therapeutic and anti-angiogenic properties for cancer therapy.

Cao S, Zhang W, Pan H, Huang Z, Guo M, Zhang L, Xu X, Saw PE. Cao S, et al. Acta Biomater. 2023 Feb;157:500-510. doi: 10.1016/j.actbio.2022.12.022. Epub 2022 Dec 17. Acta Biomater. 2023. PMID: 36535568

9

Shape Matters: Comprehensive Analysis of Star-Shaped Lipid Nanoparticles.

Cao S, Liu X, Li X, Lin C, Zhang W, Tan CH, Liang S, Luo B, Xu X, Saw PE. Cao S, et al. Front Pharmacol. 2020 Apr 30;11:539. doi: 10.3389/fphar.2020.00539. eCollection 2020. Front Pharmacol. 2020. PMID: 32425785 Free PMC article.

10

Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy.

Cao S, Saw PE, Shen Q, Li R, Liu Y, Xu X. Cao S, et al. Biomaterials. 2022 Jan;280:121264. doi: 10.1016/j.biomaterials.2021.121264. Epub 2021 Nov 19. Biomaterials. 2022. PMID: 34823884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year